BioGenes has been providing routine and highly sophisticated custom antibody development solutions for industry and research since 1992. Our track record comprises numerous demanding projects for the most difficult targets. We generate monoclonal and polyclonal antibodies targeting proteins, peptides, small molecules, modified peptides, drug substances and antibodies itself (anti-idiotypic antibodies).
BioGenes has accomplished numerous demanding projects for academic and commercial labs throughout the world. From anti-idiotypic antibodies to the development of antibodies for use in biosimilar development and antibodies for ELISAs to use in quality control of production processes, BioGenes can help you with your specific testing requirements. To give some examples, our scientists have successfully developed antibodies against various kinds of antigens, including:
- Proteins and protein mixtures, membrane protein and proteins from cell extracts
- Phosphorylated and methylated antigens
- Small organic molecules and haptens